It's good news, but the tutes who control the stock care about one thing: 7353/Zenith
4430/Galidesivir/P? Sideshow in comparison. If 7353/Zenith are really the real deal, then big pharma: CSL could make a run at them while Takeda is finalizing Shire takeover to poke them in the eye.
If they are not taken out before year end, then Stonehouse and company probably don't want to retire as they could have with the proposed merger.
They have the science and some money in the bank. Negotiate now from a position of strength. Tom, Jon, BOD....MAKE A DEAL this time.